dermatology
VIDA Score (Vitiligo Disease Activity)
Assesses disease activity in vitiligo using the Vitiligo Disease Activity (VIDA) score. Guides treatment selection (immunosuppression vs phototherapy vs surgical).
References
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Methotrexate (Dermatology — Psoriasis) · Disease-Modifying Antirheumatic / Immunosuppressant
- Pindolol · Non-selective β-blocker (with intrinsic sympathomimetic activity)
- Omalizumab (Dermatology — Chronic Urticaria) · Anti-IgE Monoclonal Antibody
- Apremilast (Dermatology) · Phosphodiesterase-4 (PDE4) Inhibitor
- Acetazolamide (Ménière's Disease) · Carbonic Anhydrase Inhibitor (Diuretic)
- Zinc acetate · Zinc salt (Wilson's disease)
Pathways
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.